Ocular Fluid Work-up in Presumed Trematode Induced Granulomatous Uveitis

NCT07885137 — Recruiting, 40 participants, Kasr El Aini Hospital

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  
RegistryNCT07885137
StatusRecruiting
Study typeObservational
Enrollment40 (Estimated)
SponsorKasr El Aini Hospital (Other)
ConditionsPresumed Trematode Induced Uveitis, Uveitis
InterventionsAC fluid sample, Vitreous fluid sample (Genetic)
Datesstart 2026-09-01, primary completion 2027-09-01 (estimated), completion 2027-12-01 (estimated), first posted 2026-10-21, last updated 2026-10-21
Locations1 site in Egypt

Related Papers Related Patents Related Grants Related Experts
All trials for Presumed Trematode Induced Uveitis All trials for Uveitis All trials of AC fluid sample All trials of Vitreous fluid sample

-Summary

Ocular Fluid Work-up in Presumed Trematode Induced Granulomatous Uveitis

Expand all sections  ·  Collapse all

+Detailed description

Patients with PTIGU of any age presenting to the Kasr Al-Aini Uveitis and Ocular Immunology Clinic who are scheduled to undergo AC wash or pars plana vitrectomy will be included in the study For all included patients, we will retrieve the age, gender, eye laterality, duration of disease, and the treatment received (topical, regional, and systemic). Careful review of systems and thorough investigations will be done as guided by clinical presentation (to exclude other causes of granulomatous uveitis). These investigations may be in the form of complete blood picture, stool and urine analysis, fluorescent treponemal antibody absorbent test, angiotensin-converting enzyme, tuberculin skin testing, toxocara antibodies, toxoplasma antibodies, and chest X-ray.

All patients will undergo thorough clinical examination including corrected distance visual acuity (CDVA), intraocular pressure (IOP) measurement, and ophthalmic findings with slit-lamp examination will be collected including the AC with associated granulomas, iris status regarding presence of synechiae, gonioscopic findings, lens status and vitreous inflammatory grades according to the Standardized Uveitis Nomenclature (SUN) classification. Dilated fundus examination with slit-lamp biomicroscopy and indirect ophthalmoscopy with scleral indentation will be explored to document the presence of retinal detachment, macula status, and grades of proliferative vitreoretinopathy (PVR). Also, B scan ultrasonography (US) will be done if media opacities precluded fundus examination. Ultrasonographic biomicroscopy (UBM) will be done to determine the presence and location of ciliary body granuloma.

All surgeries will be done under general anesthesia by the same experienced posterior segment surgeon. All eyes will receive topical antibiotics with topical prednisolone acetate 1% eye drops given every 2 hours for the first 48 hours followed by 5 times daily to be tapered according to AC reaction in addition to antibiotic combined with steroid ointment at bedtime.

Samples will be stored in sterile Epindorf tubes at -80°C. DNA will be extracted from the samples using DNeasy tissue kit (Qiagen, Hilden, Germany) according to manufacturer's.

A primer pair, CO1F (5-GATCGTA AATTTGGATACTGC-3) and CO1R (5-CCAACCATAAACATATGATG-3) targeting trematodal mitochondrial cytochrome c oxidase subunit 1 (CO1) gene will be used. PCR will be made in 25 µL reaction containing 12.5 µL MyTaq HS red Master Mix (Bioline, England), 0.5 µM of each primer and 0.5 µL DNA extract. PCR conditions will include initial denaturation at 95°C for 4 min followed by 35 cycles of denaturation at 95°C for 15 s, annealing at 54°C for 15 s and extension at 72°C for 30 s. PCR products will then be examined on 1.5% agarose gel stained with ethidium bromide to detect the expected 250 bp amplified product. In samples undergoing sequencing, the amplified products will be loaded on the gel and purified using the DNA Purification Kit (Promega, Madison, WI, USA). The cyclic sequencing reaction will be performed. Samples will be denatured at 96°C for 2 min and then cycled 28 times at 96°C for 10 s, 52°C for 10 s, and 60°C for 4 min. Unincorporated nucleotides will be removed by using sodium carbonate, 125 mmol/L EDTA, and absolute alcohol. HI-Di Formamide (Applied Biosystems) will be used to stabilize the single-strand template before preforming sequencing. Sequences will be analyzed by using BLAST for species-level identification.

+Arms and interventions

ArmTypeInterventionsDescription
Anterior UveitisGenetic: AC fluid sampleAnterior Chamber granuloma AC Wash AC fluid Sample
Intermediate / posterior UveitisGenetic: Vitreous fluid sampleCiliary body granuloma PPV and Viteous fluid sample
  • AC fluid sample (Genetic): PCR using trematoda specific primers DNA sequencing
  • Vitreous fluid sample (Genetic): PCR using trematoda specific primer DNA sequencing

+Outcome measures

Primary outcomes

  • Testing samples by PCR for DNA Detection [6 month]: detect trematodal DNA in the ocular fluid of presumed trematode-induced uveitis by using PCR
  • Organism detection [6 month]: identify the organism responsible for trematode-induced uveitis through DNA sequence analysis of genetic material extracted from ocular fluid.

+Eligibility

Sex: All

Inclusion Criteria:

* Patients with Presumed Trematode-Induced Uveitis scheduled for AC wash or pars plana vitrectomy of any age.

Exclusion Criteria:

* Causes of granulomatous uveitis other than trematodal infection.
* Inconclusive UBM findings.
* Ocular trauma.
* Previous ocular surgeries including (anterior chamber wash for AC granulomas).

+Locations (1)

FacilityCityCountryStatus
Faculty of Medicine Cairo University Kasr Al Ainy HospitalCairo, Giza GovernorateEgyptRecruiting

+Publications

  • 1. El Nokrashy, A., Abou Samra, W., Sobeih, D. et al. Treatment of presumed trematode-induced granulomatous anterior uveitis among children in rural areas of Egypt. Eye 33, 1525-1533 (2019). 2. Rathinam SR, Usha KR, Rao NA. Presumed trematode-induced granulomatous anterior uveitis: a newly recognized cause of intraocular inflammation in children from south India. Am J Ophthalmol. 2002 Jun;133(6):773-9. 3. Rathinam S, Fritsche TR, Srinivasan M, Vijayalakshmi P, Read RW, Gautom R, et al. An outbreak of trematode-induced granulomas of the conjunctiva. Ophthalmology. 2001;108(7):1223-9. 4. Amin RM, Goweida MB, El Goweini HF, Bedda AM, Lotfy WM, Gaballah AH, et al. Trematodal granulomatous uveitis in paediatric Egyptian patients: A case series. Br J Ophthalmol. 2017;101(8):999-1002. 5. Amin RH, Abdullatif AM. Management of presumed trematode-induced granulomatous intermediate uveitis. Eye. 2023;37(11):2299-304. 6. Amin RM, Goweida M, Bedda A, Kamel A, Radwan A. Clinical patterns and causes of intraocular inflammation in a uveitis patient cohort from Egypt. Ocul Immunol Inflamm. 2016;26:1-9 7. Arya LK, Rathinam SR, Lalitha P, Kim UR, Ghatani S, Tandon V. Trematode fluke Procerovum varium as cause of ocular inflammation in children, South India. Emerg Infect Dis. 2016;22(2):192-200. 8. Rathinam SR, Arya LK, Usha KR, Prajna L, Tandon V. Novel etiological agent: molecular evidence for trematode-induced anterior uveitis in children. Arch Ophthalmol. 2012;130:1481-4. 9. Amin RM, Radwan AE, Goweida MB, El Goweini HF, Bedda AM, Lotfy WM, et al. Management of presumed trematode induced granulomatous uveitis in pediatric patients. Jpn J Ophthalmol. 2019;63(1):119-25. 10. El Nokrashy A, Abou Samra W, Sobeih D, Lamin A, Hashish A, Tarshouby S, et al. Treatment of presumed trematode-induced granulomatous anterior uveitis among children in rural areas of Egypt. Eye. 2019;33(10):1525-33.

+Study documents